Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Molecular studies probe bipolar disorder.

Friedrich MJ.

JAMA. 2005 Feb 2;293(5):535-6. No abstract available.

PMID:
15687298
2.

Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.

Einat H, Manji HK.

Biol Psychiatry. 2006 Jun 15;59(12):1160-71. Epub 2006 Feb 2. Review.

PMID:
16457783
3.

Mood stabilizers: protecting the mood...protecting the brain.

Brunello N.

J Affect Disord. 2004 Apr;79 Suppl 1:S15-20.

PMID:
15121343
4.

Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo.

Chen G, Masana MI, Manji HK.

Bipolar Disord. 2000 Sep;2(3 Pt 2):217-36. Review.

PMID:
11249800
5.

[Mechanism of action of lithium: intracellular signaling pathways].

Zorrilla Zubilete M.

Vertex. 2003 Mar-May;14(51):45-52. Review. Spanish.

PMID:
12690409
6.

Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.

Gould TD, Zarate CA, Manji HK.

J Clin Psychiatry. 2004 Jan;65(1):10-21. Review.

PMID:
14744163
7.

Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression.

Du J, Gray NA, Falke CA, Chen W, Yuan P, Szabo ST, Einat H, Manji HK.

J Neurosci. 2004 Jul 21;24(29):6578-89.

8.

The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder.

Mitchell PB.

Aust N Z J Psychiatry. 1999 Dec;33 Suppl:S99-107. Review.

PMID:
10622184
9.

Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients.

Silverstone PH, Asghar SJ, O'Donnell T, Ulrich M, Hanstock CC.

World J Biol Psychiatry. 2004 Jan;5(1):38-44. Review.

PMID:
15048634
11.

Methodologies to avoid the enrollment of ineligible patients in clinical trials.

Tohen M.

J Clin Psychiatry. 2012 Nov;73(11):1426-7. doi: 10.4088/JCP.12com08119. No abstract available.

12.

Valproate and neuroprotective effects for bipolar disorder.

Atmaca M.

Int Rev Psychiatry. 2009;21(4):410-3. doi: 10.1080/09540260902962206. Review.

PMID:
20374154
13.

Clinical correlates of therapeutic response in bipolar disorder.

Bowden CL.

J Affect Disord. 2001 Dec;67(1-3):257-65. Review.

PMID:
11869775
14.

The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems.

Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ.

J Pharmacol Exp Ther. 2003 May;305(2):434-9. Epub 2003 Jan 24.

15.

Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.

Manji HK, McNamara R, Chen G, Lenox RH.

Aust N Z J Psychiatry. 1999 Dec;33 Suppl:S65-83. Review.

PMID:
10622182
16.

Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.

Manji HK, Moore GJ, Chen G.

Br J Psychiatry Suppl. 2001 Jun;41:s107-19. Review.

PMID:
11450170
17.

Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder.

Xie X, Hagan RM.

Neuropsychobiology. 1998 Oct;38(3):119-30. Review.

PMID:
9778599
18.

The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.

Gray NA, Zhou R, Du J, Moore GJ, Manji HK.

J Clin Psychiatry. 2003;64 Suppl 5:3-17. Review.

19.

Expression of G-proteins and regulators of G-protein signalling in neutrophils of patients with bipolar disorder: effects of mood stabilizers.

Willmroth F, Spleiss O, Wiesmann K, Moser D, Atmanspacher R, van Calker D.

Bipolar Disord. 2002;4 Suppl 1:75-6. No abstract available.

PMID:
12479685
20.

Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.

Zarate CA Jr, Singh J, Manji HK.

Biol Psychiatry. 2006 Jun 1;59(11):1006-20. Epub 2006 Feb 17. Review.

PMID:
16487491

Supplemental Content

Support Center